Follow

Get every new post on this blog delivered to your Inbox.

Join other followers:


 

logo
347-787-6824

Blog

blog

Blog rss feed

In addition to your RSS feed subscription, you can also sign up for the Firm’s Blog & Press Release post notification by entering your e-mail address and clicking “Subscribe” below.

 


Welcome to the LAW FIRM OF DAYREL SEWELL, PLLC. Thank you for visiting the Blog section of this firm. We will be updating this page with information about the firm, recent legal updates, and other legal issues.

HSBC Sued by NY A.G. Over Foreclosure Abuse

HSBC Sued by NY A.G. Over Foreclosure Abuse Today, the New York State Attorney General’s Office (AGO) announced that it has filed suit against HSBC Bank USA and HSBC Mortgage Corporation (USA) in NY State Supreme Court in Erie County. See THE PEOPLE OF THE STATE OF NY vs. HSBC BANK USA. The lawsuit states that HSBC is failing to follow state law related to foreclosure actions, thereby putting homeowners at greater risk of losing their homes.   Background   In New York, loans for real property are secured through mortgages rather than through deeds of trust. New York, unlike trust states, is a judicial foreclosure state. In states like New York, mortgage foreclosure actions must proceed through the judiciary Read More

Posted in Blog | 4 Comment

“First-Sale” Resellers Rejoice

“First-Sale” Resellers Rejoice SUPREME COURT OF THE UNITED STATES KIRTSAENG, DBA BLUECHRISTINE99 (Petitioner) v. JOHN WILEY & SONS, INC. (Respondent) No. 11–697. Argued October 29, 2012—Decided March 19, 2013   COMMENT   Recently, a seminal decision was issued by the Supreme Court of the United States that undoubtedly affects the scope of rights for copyright holders as well as the resellers of those copyrighted works.   Background   John Wiley & Sons, Inc., an academic textbook publisher, often assigns to its wholly owned foreign subsidiary (Wiley Asia) rights to publish, print, and sell foreign editions of Wiley’s E Read More

Posted in Blog | 8 Comment

After Patent Life, FDA says NO to Generic OxyContin

After Patent Life, FDA says NO to Generic OxyContin Background   Under the Food, Drug, & Cosmetic (FD&C) Act and implementing regulations, the Food and Drug Administration (FDA) is responsible for ensuring that all new drugs are safe and effective. FDA also regulates the advertising and promotion of prescription drugs under the FD&C Act.   Purdue Pharma L.P., based in Stamford, CT, is a privately held pharmaceutical company founded by physicians. The FDA approved Purdue Pharma’s controlled-release pain reliever OxyContin in 1995. OxyContin (oxycodone hydrochloride controlled-release) is an opioid analgesic supplied in various dosages for oral administration. OxyContin is Purdue’s brand for tim Read More

Posted in Blog | 1 Comment

Untitled-1